PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Lin Xu to Speak at Molecular Imaging Drug Conference May 8-10, 2013 in Boston, Massachusetts - Lin Xu, Principle Scientist at Biogen Idec to Present at the 6th Imaging in Drug Discovery and Development Conference, to be held onMay 8-10, 2013 in Boston, MA - GTCbio.com
Lin Xu to Speak at Molecular Imaging Drug Conference May 8-10, 2013 in Boston, Massachusetts

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/01/24 - Lin Xu, Principle Scientist at Biogen Idec to Present at the 6th Imaging in Drug Discovery and Development Conference, to be held onMay 8-10, 2013 in Boston, MA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Lin Xu, Principle Scientist at Biogen Idec, to present “Imaging Drug And Metabolites In Target Tissue Using Ambient Surface Sampling Mass Spectrometry” at the 6th Imaging in Drug Discovery and Development Conference to be held in Boston, MA on May 8-10, 2013 by GTC.

Understanding the tissue distribution of drug entities is an essential step in drug development. Localization of the drug at the target site enhances confidence in the mechanism of action. It can help to demonstrate specific target organ localization and to support claims regarding the duration of action.
In order to understand drug distribution at the target tissue in a simple and quick approach, Dr. Xu and his team applied recently developed MS based surface sampling techniques, desorption electrospray ionization (DESI) and liquid extraction surface analysis (LESA). The advantages of these techniques over autoradiography and LC-MS were successfully demonstrated in the analysis of the distribution of drug A and its metabolites in rat brain tissue. The dynamic distribution of the drug candidate was found to differ in the white and gray matter of the brain (target tissue). The distribution of the major metabolites was also different; the oxidized metabolite displayed a homogenous distribution while the desaturated metabolite tracked with the parent drug.

Dr. Lin Xu is a Principle Scientist in the Drug Metabolism and Pharmacokinetic Department at Biogen Idec. He earned his Bachelor of Science in Chemistry at Nankai University in China and Ph.D. in Organic Chemistry at the University of British Columbia. In his postdoctoral fellowship at University of Rochester Medical Center, Dr. Xu identifed N-EtFOSE metabolites and elucidated N-EtFOSE metabolic pathway in vitro and vivo using LC/MS/MS by collaborating with the toxicological department at 3M Corporation. After he joined Merck, Dr. Xu participated as a DMPK representative in drug discovery teams to perform and design drug metabolism, pharmacokinetic studies, and biotransformation study and PK/PD modeling. In his current role at Biogen Idec, Dr. Xu manages in vitro and in vivo biotransformation studies to support drug discovery and drug development for regulatory agency filings. He has contributed over 20 publications to the drug metabolism and toxicology society.

GTC’s 6th Imaging in Drug Discovery and Development Conference brings together experts from academia, government, and industry from the National Cancer Institute, Stanford University, City of Hope and the Beckman Research Institute, Yale School of Medicine, Pfizer, Biogen Idec, PerkinElmer, Eisai, Columbia University, Roche, Sanofi-Aventis, Janssen, and many more to discuss the latest developments and applications in imaging to further advance their molecular imaging projects on drug discovery and development.

This conference is also part of the Drug Discovery Summit 2013, which consists of this track and three other tracks:

7th Drug Design and Medicinal Chemistry
3rd Epigenetics in Drug Discovery
Orphan Drugs Research and Commercialization

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Lin Xu to Speak at Molecular Imaging Drug Conference May 8-10, 2013 in Boston, Massachusetts

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)